Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
India
/
Healthcare
/
Max Healthcare Institute
543220
Max Healthcare Institute
Northern India Risks And Rising Capex Will Burden Future Operations
AN
AnalystLowTarget
Not Invested
Consensus Narrative from 23 Analysts
Published
17 Jun 25
Updated
20 Aug 25
0
Set Fair Value
0
votes
Share
AnalystLowTarget
's Fair Value
₹894.26
38.1% overvalued
intrinsic discount
20 Aug
₹1,235.10
Loading
1Y
44.8%
7D
1.2%
Author's Valuation
₹894.3
38.1% overvalued
intrinsic discount
AnalystLowTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystLowTarget Fair Value
₹894.3
38.1% overvalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
-2b
128b
2015
2017
2019
2021
2023
2025
2027
2028
Revenue ₹128.2b
Earnings ₹26.8b
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
23.20%
Healthcare Services revenue growth rate
0.26%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
12.73%
Calculation
₹26.85b
Earnings '28
x
46.33x
PE Ratio '28
=
₹1.24t
Market Cap '28
₹1.24t
Market Cap '28
/
970.78m
No. shares '28
=
₹1.28k
Share Price '28
₹1.28k
Share Price '28
Discounted to 2025 @ 12.73% p.a.
=
₹894.47
Fair Value '25